Procedure
AD-cSVF
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_1
3
100%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Other(3)
Detailed Status
Suspended3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 13 (100.0%)
Trials by Status
suspended3100%
Recent Activity
0 active trials
Showing 3 of 3
suspendedphase_1
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders
NCT02946658
suspendedphase_1
Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)
NCT03909750
suspendedphase_1
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease
NCT02952131
Clinical Trials (3)
Showing 3 of 3 trials
NCT02946658Phase 1
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders
NCT03909750Phase 1
Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)
NCT02952131Phase 1
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3